Does GLATIRAMER Cause Central nervous system lesion? 492 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 492 reports of Central nervous system lesion have been filed in association with GLATIRAMER (GLATIRAMER ACETATE). This represents 1.1% of all adverse event reports for GLATIRAMER.
492
Reports of Central nervous system lesion with GLATIRAMER
1.1%
of all GLATIRAMER reports
2
Deaths
35
Hospitalizations
How Dangerous Is Central nervous system lesion From GLATIRAMER?
Of the 492 reports, 2 (0.4%) resulted in death, 35 (7.1%) required hospitalization.
Is Central nervous system lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLATIRAMER. However, 492 reports have been filed with the FAERS database.
What Other Side Effects Does GLATIRAMER Cause?
Injection site pain (5,003)
Multiple sclerosis relapse (3,695)
Drug ineffective (3,321)
Injection site reaction (3,317)
Multiple sclerosis (2,596)
Injection site erythema (2,560)
Fatigue (2,408)
Dyspnoea (2,364)
Injection site mass (2,172)
Injection site swelling (1,836)
What Other Drugs Cause Central nervous system lesion?
FINGOLIMOD (2,416)
DIMETHYL (1,152)
INTERFERON BETA-1A (978)
NATALIZUMAB (627)
DALFAMPRIDINE (561)
TERIFLUNOMIDE (315)
ADALIMUMAB (229)
OFATUMUMAB (185)
RITUXIMAB (151)
METHOTREXATE (147)
Which GLATIRAMER Alternatives Have Lower Central nervous system lesion Risk?
GLATIRAMER vs GLECAPREVIR\PIBRENTASVIR
GLATIRAMER vs GLEEVEC
GLATIRAMER vs GLICLAZIDE
GLATIRAMER vs GLIMEPIRIDE
GLATIRAMER vs GLIMEPIRIDE\ROSIGLITAZONE